arrow
D

David P. Walling

cenexel cns, garden grove, california, usa
H指数:29
被引数:3,456

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and Efficacy of the NMDA-2b-Selective Negative Allosteric Modulator BI 1569912: A Phase Ib Randomized Trial in Major Depressive Disorder

NMDA-2b-选择性负性别构调节剂BI 1569912的安全性与有效性:一项在重度抑郁症中的Phase Ib随机试验

2025-08-140
PREAI
Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials

xanomeline和trospium chloride在精神分裂症中的疗效: 来自三个5周,随机,双盲,安慰剂对照,紧急试验的汇总结果

2024-11-026
OAAI
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers

在精神分裂症和健康志愿者的竞争前,行业主导的研究中验证一套ERP和QEEG生物标志物

2023-04-0112
OAAI
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
LANCET
IF88.5
2019-02-01194
PREAI